Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 1
2010 2
2011 5
2012 2
2013 3
2014 4
2015 8
2016 6
2017 18
2018 21
2019 5
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 29025008

76 results
Results by year
Filters applied: . Clear all
Page 1
Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.
Jabbal S, Anderson W, Short P, Morrison A, Manoharan A, Lipworth BJ. Jabbal S, et al. QJM. 2017 Dec 1;110(12):785-792. doi: 10.1093/qjmed/hcx155. QJM. 2017. PMID: 29025008
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
Oba Y, Keeney E, Ghatehorde N, Dias S. Oba Y, et al. Cochrane Database Syst Rev. 2018 Dec 3;12(12):CD012620. doi: 10.1002/14651858.CD012620.pub2. Cochrane Database Syst Rev. 2018. PMID: 30521694 Free PMC article.
Tolerability of Bisoprolol on Domiciliary Spirometry in COPD.
Jabbal S, Lipworth BJ. Jabbal S, et al. Lung. 2018 Feb;196(1):11-14. doi: 10.1007/s00408-017-0061-y. Epub 2017 Oct 14. Lung. 2018. PMID: 29030687
The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
Sousa AR, Riley JH, Church A, Zhu CQ, Punekar YS, Fahy WA. Sousa AR, et al. NPJ Prim Care Respir Med. 2016 Jun 23;26:16031. doi: 10.1038/npjpcrm.2016.31. NPJ Prim Care Respir Med. 2016. PMID: 27334739 Free PMC article. Clinical Trial.
Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.
Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Samp JC, et al. Pharmacotherapy. 2017 Apr;37(4):447-455. doi: 10.1002/phar.1913. Pharmacotherapy. 2017. PMID: 28226405 Clinical Trial.
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K. Rodrigo GJ, et al. Int J Chron Obstruct Pulmon Dis. 2017 Mar 17;12:907-922. doi: 10.2147/COPD.S130482. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28360514 Free PMC article. Review.
Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis.
Aziz MIA, Tan LE, Wu DB, Pearce F, Chua GSW, Lin L, Tan PT, Ng K. Aziz MIA, et al. Int J Chron Obstruct Pulmon Dis. 2018 Oct 9;13:3203-3231. doi: 10.2147/COPD.S173472. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30349228 Free PMC article.
Initiation of Triple Therapy with Multiple Inhalers in Chronic Obstructive Pulmonary Disease: An Analysis of Treatment Patterns from a U.S. Retrospective Database Study.
Lane DC, Stemkowski S, Stanford RH, Tao Z. Lane DC, et al. J Manag Care Spec Pharm. 2018 Nov;24(11):1165-1172. doi: 10.18553/jmcp.2018.24.11.1165. J Manag Care Spec Pharm. 2018. PMID: 30362922 Free article.
76 results
Jump to page
Feedback